LBO — PROVIDENCE ALASKA MEDICAL CENTER
IRR: 19.7% | MOIC: 2.46x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
19.7%
IRR
2.46x
MOIC
$518.5M
Entry EV
$879.8M
Exit EV
$266.8M
Equity Invested
Sources & Uses
S&UTotal · $518.5M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $201.3M | 38.8% | |
| Sub Debt | $50.3M | 9.7% | |
| Equity | $266.8M | 51.5% | |
| Enterprise Value | $503.4M | 97.1% | |
| Transaction Fees | $15.1M | 2.9% | |
| Total Uses | $518.5M | 100.0% |
Interpretation
INTAt 2.46x MOIC and 19.7% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $83.8M |
| Exit Ev | $879.8M |
| Net Debt At Exit | $224.7M |
| Equity At Exit | $655.1M |
| Equity Invested | $266.8M |
| Total Value Created | $388.3M |
| Value From Growth | $351.2M |
| Value From Multiple | $25.2M |
| Value From Deleveraging | $27.0M |